[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346740-105":59,"doc-detail-346740-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-risk-of-infection-related-malignancies-and-tumor-mutational-burden-in-immunocompromised-hosts-a-systematic-review-and-meta-analysis","The risk of infection-related malignancies and tumor mutational burden in immunocompromised hosts - a systematic review and meta-analysis","","Immunocompromised individuals face elevated malignancy risk due to impaired immune surveillance and increased susceptibility to oncogenic infections, leading to distinct immunotherapy responses. Yet the cancer risk mechanisms tied to infection remain insufficiently clarified, as do the feasibility and efficacy of immunotherapy in these populations. This systematic review searched PubMed, Web of Science, EMBASE, Medline, and Cochrane Library through Nov 10, 2024, and synthesized evidence using a random-effects meta-analytic approach.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-risk-of-infection-related-malignancies-and-tumor-mutational-burden-in-immunocompromised-hosts-a-systematic-review-and-meta-analysis/346740/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-risk-of-infection-related-malignancies-and-tumor-mutational-burden-in-immunocompromised-hosts-a-systematic-review-and-meta-analysis/346740.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What populations are included in the systematic review?","Question",{"text":112,"@type":113},"The review focuses on solid organ transplant recipients, hematopoietic stem cell transplant recipients, and people living with HIV or AIDS, comparing cancer risks to the general population.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the evidence synthesized in the meta-analysis?",{"text":117,"@type":113},"A comprehensive search was performed in PubMed, Web of Science, EMBASE, Medline, and Cochrane Library up to Nov 10, 2024. A random-effects model was pre-specified to address expected clinical and methodological heterogeneity, with heterogeneity quantified using I².",{"name":119,"@type":110,"acceptedAnswer":120},"What relationship was found between tumor mutational burden (TMB) and cancer risk?",{"text":121,"@type":113},"A statistically significant correlation between TMBs and standardized incidence ratios was observed in solid organ transplant recipients and people living with HIV, but no significant association was detected in hematopoietic stem cell transplant recipients.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346740,1790140410,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Chen et al. BMC Cancer (2026) 26:406 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15752-6](https://doi.org/10.1186/s12885-026-15752-6)  \nSYSTEMATIC REVIEW Open Access  \nThe risk of infection-related malignancies and tumor mutational burden in immunocompromised hosts: a systematic review and meta-analysis  \nRong Chen1†, Zhenyu Huo2†, Xuelin Yang3†, Xiaohu Cui4, Xin Liu3 and Fang Wang1,5*  \nAbstract  \nBackground Immunocompromised individuals exhibit an increased risk of malignancies attributable to impaired immune surveillance and increased susceptibility to oncogenic infections, resulting in distinct responses to immunotherapy. The intricacies of infection-related cancer risks and the feasibility and efficacy of immunotherapy in these patients remain inadequately understood.  \nMethods A comprehensive search of PubMed, Web of Science, EMBASE, Medline, and Cochrane Library was conducted up to Nov 10, 2024. A random-effects model was pre-specified as the primary analytical method to account for anticipated clinical and methodological heterogeneity among the included studies. Heterogeneity was quantified using the I2 statistic. Tumor mutational burdens (TMBs) were assessed for Spearman correlation with standardized incidence ratios (SIRs) .  \nResults This systematic review included 151 studies, comprising 74 in solid organ transplant (SOT), 15 in hematopoietic stem cell transplant (HSCT), and 62 in people living with HIV (PLHIV) . The analysis encompassed 2,418,274 SOT recipients, 117,264 HSCT recipients, and 5,762,641 PLHIV, covering 17 infection-related cancers. Excluding nasopharyngeal cancer, 16 cancers showed higher SIRs in SOT recipients and PLHIV compared to the general population. A statistically significant correlation was observed between TMBs and SIRs in SOT recipients (Spearman’s ρ = 0 . 85, P = 0 . 002), with consistent findings across key subgroups (kidney [Spearman’s ρ = 0 . 92, P \u003C 0. 001], liver [Spearman’s ρ = 0.91 (P \u003C 0. 001)], heart and/or lung [Spearman’s ρ = 0 . 74, P = 0 . 023]), and PLHIV (Spearman’s ρ = 0 . 89, P = 0 . 002), whereas no significant association was detected in HSCT recipients (Spearman’s ρ = 0 . 15, P = 0 . 805) . Conclusion These findings suggest that TMBs from infections or immunosuppression may contribute to cancer risk, emphasizing the potential of immune checkpoint inhibitors despite rejection risks. Personalized cancer surveillance and tailored therapies are essential for immunosuppressed populations.  \nTrial registration PROSPERO protocol ID CRD42024594181 .  \n†Rong Chen, Zhenyu Huo and Xuelin Yang are joint first authors.  \n*Correspondence:  \nFang Wang [wang.fang@imicams.ac.cn](wang.fang@imicams.ac.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nChen et al. BMC Cancer (2026) 26:406 Page 2 of 13  \nKeywords Solid organ transpla","cbCaiaHRqe9XWuFD","https://ap.wps.com/l/cbCaiaHRqe9XWuFD","pdf",2827554,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n## Trial registration\n## Keywords\n# Introduction","[{\"question\":\"What populations are included in the systematic review?\",\"answer\":\"The review focuses on solid organ transplant recipients, hematopoietic stem cell transplant recipients, and people living with HIV or AIDS, comparing cancer risks to the general population.\"},{\"question\":\"How was the evidence synthesized in the meta-analysis?\",\"answer\":\"A comprehensive search was performed in PubMed, Web of Science, EMBASE, Medline, and Cochrane Library up to Nov 10, 2024. A random-effects model was pre-specified to address expected clinical and methodological heterogeneity, with heterogeneity quantified using I².\"},{\"question\":\"What relationship was found between tumor mutational burden (TMB) and cancer risk?\",\"answer\":\"A statistically significant correlation between TMBs and standardized incidence ratios was observed in solid organ transplant recipients and people living with HIV, but no significant association was detected in hematopoietic stem cell transplant recipients.\"}]","The risk of infection-related malignancies and tumor mutational burden in immunocompromised hosts - a systematic review and meta-analysis | PDF",1790062608,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/682a7a128946ae7322da6304b9b88976.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/602b9deb379dac3c07ef48e1e7adc15f.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/943b335ae002fdd87becaa463e487d94.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6cd6c15144dc83d43ef3cd9bb43a876e.webp",980,1306]